Quantification of microRNA-210 in the cerebrospinal fluid and serum: Implications for Alzheimer's disease

Publisher： Spandidos Publications

E-ISSN： 1792-1015|9|3|1013-1017

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.9, Iss.3, 2015-03, pp. : 1013-1017

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MicroRNA-193b is a regulator of amyloid precursor protein in the blood and cerebrospinal fluid derived exosomal microRNA-193b is a biomarker of Alzheimer's disease

By        

Molecular Medicine Reports, Vol. 10, Iss. 5, 2014-01 ,pp. : 2395-2400

Spandidos Publications

Access to resources Recommend Favorite

A single nucleotide polymorphism in primarymicroRNA146a reduces the expression of mature microRNA146a in patients with Alzheimer's disease and is associated with the pathogenesis of Alzheimer's disease

By          

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 4037-4042

Spandidos Publications

Access to resources Recommend Favorite

Serum microRNA-125a-5p, a useful biomarker in liver diseases, correlates with disease progression

By                  

Molecular Medicine Reports, Vol. 12, Iss. 1, 2015-01 ,pp. : 1584-1590

Spandidos Publications

Access to resources Recommend Favorite

Downregulation of microRNA210 inhibits osteosarcoma growth in vitro and in vivo

By    

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3674-3680

Spandidos Publications

Access to resources Recommend Favorite

Bioinformatic analysis of microRNA expression in Parkinson's disease

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 1079-1084

Spandidos Publications

Access to resources Recommend Favorite